Literature DB >> 22257586

Cardiovascular magnetic resonance in pulmonary hypertension.

William M Bradlow1, J Simon R Gibbs, Raad H Mohiaddin.   

Abstract

Pulmonary hypertension represents a group of conditions characterized by higher than normal pulmonary artery pressures. Despite improved treatments, outcomes in many instances remain poor. In recent years, there has been growing interest in the use of cardiovascular magnetic resonance (CMR) in patients with pulmonary hypertension. This technique offers certain advantages over other imaging modalities since it is well suited to the assessment of the right ventricle and the proximal pulmonary arteries. Reflecting the relatively sparse evidence supporting its use, CMR is not routinely recommended for patients with pulmonary hypertension. However, it is particularly useful in patient with pulmonary arterial hypertension associated with congenital heart disease. Furthermore, it has proven informative in a number of ways; illustrating how right ventricular remodeling is favorably reversed by drug therapies and providing explicit confirmation of the importance of the right ventricle to clinical outcome. This review will discuss these aspects and practical considerations before speculating on future applications.

Entities:  

Mesh:

Year:  2012        PMID: 22257586      PMCID: PMC3305675          DOI: 10.1186/1532-429X-14-6

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  75 in total

1.  Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

Authors:  Kevin G Blyth; Bjoern A Groenning; Thomas N Martin; John E Foster; Patrick B Mark; Henry J Dargie; Andrew J Peacock
Journal:  Eur Heart J       Date:  2005-05-17       Impact factor: 29.983

2.  Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension.

Authors:  Matthias Spindler; Michael Schmidt; Oliver Geier; Jörn Sandstede; Dietbert Hahn; Georg Ertl; Meinrad Beer
Journal:  J Cardiovasc Magn Reson       Date:  2005       Impact factor: 5.364

3.  Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension.

Authors:  Gerry P McCann; Aernout M Beek; Anton Vonk-Noordegraaf; Albert C van Rossum
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

4.  A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension.

Authors:  Roald J Roeleveld; J Tim Marcus; Anco Boonstra; Pieter E Postmus; Koen M Marques; Jean G F Bronzwaer; Anton Vonk-Noordegraaf
Journal:  J Magn Reson Imaging       Date:  2005-07       Impact factor: 4.813

5.  Impaired stroke volume response to exercise in pulmonary arterial hypertension.

Authors:  Sebastiaan Holverda; C Tji-Joong Gan; J Tim Marcus; Pieter E Postmus; Anco Boonstra; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2006-03-29       Impact factor: 24.094

6.  Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension.

Authors:  S A van Wolferen; A Boonstra; J T Marcus; K M J Marques; J G F Bronzwaer; P E Postmus; A Vonk-Noordegraaf
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

Review 7.  Pulmonary arterial hypertension: the key role of echocardiography.

Authors:  Eduardo Bossone; Bruno Dino Bodini; Alfredo Mazza; Luigi Allegra
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

8.  Modified RV short axis series--a new method for cardiac MRI measurement of right ventricular volumes.

Authors:  Wendy E Strugnell; l Richard E Slaughter; Robyn A Riley; Andrew J Trotter; Harry Bartlett
Journal:  J Cardiovasc Magn Reson       Date:  2005       Impact factor: 5.364

9.  Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance.

Authors:  Alicia M Maceira; Sanjay K Prasad; Mohammed Khan; Dudley J Pennell
Journal:  Eur Heart J       Date:  2006-11-06       Impact factor: 29.983

10.  Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.

Authors:  Martin R Wilkins; Gideon A Paul; Julian W Strange; Nina Tunariu; Wendy Gin-Sing; Winston A Banya; Mark A Westwood; Alexander Stefanidis; Leong L Ng; Dudley J Pennell; Raad H Mohiaddin; Petros Nihoyannopoulos; J Simon R Gibbs
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

View more
  24 in total

1.  Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study.

Authors:  Michael Pienn; Gabor Kovacs; Maria Tscherner; Alexander Avian; Thorsten R Johnson; Peter Kullnig; Rudolf Stollberger; Andrea Olschewski; Horst Olschewski; Zoltán Bálint
Journal:  Eur Radiol       Date:  2013-12-06       Impact factor: 5.315

Review 2.  Imaging of Chronic Thromboembolic Disease.

Authors:  Adina Haramati; Linda B Haramati
Journal:  Lung       Date:  2020-03-12       Impact factor: 2.584

3.  Evaluation of two-dimensional strain echocardiography for quantifying right ventricular function in patients with pulmonary arterial hypertension.

Authors:  Yong Liu; Yong Wang; Yingying Wang; Zhe Wen
Journal:  Exp Ther Med       Date:  2017-06-12       Impact factor: 2.447

4.  Multiparametric Magnetic Resonance Imaging in the Assessment of Pulmonary Hypertension: Initial Experience of a One-Stop Study.

Authors:  Gisela M B Meyer; Fernanda B Spilimbergo; Stephan Altmayer; Gabriel S Pacini; Matheus Zanon; Guilherme Watte; Edson Marchiori; Bruno Hochhegger
Journal:  Lung       Date:  2018-02-12       Impact factor: 2.584

5.  Right Ventricular Longitudinal Strain Reproducibility Using Vendor-Dependent and Vendor-Independent Software.

Authors:  Zachary J Il'Giovine; Hillary Mulder; Karen Chiswell; Kristine Arges; Jennifer Tomfohr; Abraham Hashmi; Eric J Velazquez; Joseph A Kisslo; Zainab Samad; Sudarshan Rajagopal
Journal:  J Am Soc Echocardiogr       Date:  2018-03-07       Impact factor: 5.251

Review 6.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

7.  NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension Diagnosis.

Authors:  Li-Huang Zha; Jun Zhou; Tang-Zhiming Li; Hui Luo; Jing-Ni He; Lin Zhao; Zai-Xin Yu
Journal:  Aging Dis       Date:  2018-10-01       Impact factor: 6.745

Review 8.  Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension.

Authors:  Mark L Schiebler; Sanjeev Bhalla; James Runo; Nizar Jarjour; Alejandro Roldan; Naomi Chesler; Christopher J François
Journal:  J Thorac Imaging       Date:  2013-05       Impact factor: 3.000

9.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Authors:  Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach
Journal:  Eur Radiol       Date:  2016-09-20       Impact factor: 5.315

10.  Three-dimensional biventricular strains in pulmonary arterial hypertension patients using hyperelastic warping.

Authors:  Hua Zou; Shuang Leng; Ce Xi; Xiaodan Zhao; Angela S Koh; Fei Gao; Ju Le Tan; Ru-San Tan; John C Allen; Lik Chuan Lee; Martin Genet; Liang Zhong
Journal:  Comput Methods Programs Biomed       Date:  2020-01-17       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.